PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,822,006 | -37.7% | 47,190 | -14.1% | 0.47% | -40.1% |
| Q3 2022 | $2,924,000 | -10.3% | 54,966 | -1.7% | 0.79% | +3.5% |
| Q2 2022 | $3,259,000 | -21.7% | 55,902 | +2.5% | 0.76% | -10.4% |
| Q1 2022 | $4,162,000 | +26.4% | 54,535 | -0.4% | 0.85% | +26.7% |
| Q4 2021 | $3,294,000 | +10.5% | 54,744 | +2.9% | 0.67% | +3.4% |
| Q3 2021 | $2,980,000 | +60.7% | 53,207 | +74.1% | 0.65% | +54.7% |
| Q2 2021 | $1,854,000 | +20.0% | 30,561 | +38.7% | 0.42% | +11.7% |
| Q1 2021 | $1,545,000 | – | 22,041 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |